Why did Iconovo stock fall on 7 October?
Written after the close on
Iconovo −10.57%
Iconovo fell very sharply with the market. Over the last five trading days Iconovo fell sharply, more than a slightly weaker OMX Stockholm 30, with the steepest drop in the most recent session. Iconovo is a development-stage inhaler specialist, so its share price usually reacts to clinical trial or partnership news rather than to earnings. Watch for any update on its clinical programmes or licensing deals, which is what typically moves this stock.